Corporate Banner
Satellite Banner
Genomics
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Aridhia Wins Genomics England Competition

Published: Thursday, May 08, 2014
Last Updated: Wednesday, May 07, 2014
Bookmark and Share
Company wins Genomics England-led SBRI competition to accelerate the adoption of genomics medicine.

Aridhia has won a Genomics England-led Small Business Research Initiative (SBRI) competition to accelerate the development of data management and analytical techniques that will help Genomics England transfer genomic science to genomic medicine within the NHS.

Aridhia’s bid focused on the scale and accuracy of the analytics required to deliver genomic medicine as a routine service by enabling the industrialization of multiple annotation pipelines from different sequence and bio-informatics providers.

If healthcare and research organizations are to deliver on the promise of genomic medicine, considerable developments around the integration, clinical validation and curation of large scale clinical and genomic datasets remain.

The objective of the competition was to discover innovative technologies that would address the requirements of Genomics England’s 100k Genome Project and demonstrate that the solution could provide the NHS with meaningful and actionable data based on patients’ genetic material, with the goal of making this data a routine part of clinical decision making.

The Department of Health is investing up to £10m in this competition, which will be managed by Genomics England Limited and which is expected to run in two phases.

The work will be carried out at the Stratified Medicine Scotland Innovation Centre on AnalytiXagility, the recently launched healthcare and research data science platform developed by Aridhia. The consortium of specialists involved in the project and led by Aridhia includes Fios Genomics, EMC and Pivotal.

David Sibbald, CEO of Aridhia, explains: “Clinical interpretation of sequence data can inform likely disease progression, prognosis and can identify potential response to treatment. Ultimately this could lead to improved treatment success rates and reduce unnecessary side effects. One of the key challenges is the availability of industrial-strength annotation pipelines that can be deployed at scale and integrated effectively with a range of other data associated with patient care and treatment.”

Whole genome sequencing is predominantly a research activity today with genomic annotation currently a limited add-on to diagnostics. The Aridhia-led collaboration aims to develop an innovative set of annotation services technologies, based on its existing AnalytiXagility platform, which will address the challenges of delivering clinically relevant reports, as well as the operational challenges in storing and linking genomic and phenotype data.

The ultimate aim is to identify the best way to present this information to clinicians in an easily interpreted format, giving the NHS access to clinically relevant, actionable information which can be used to directly influence patient care.

The project will run in two phases. Firstly the AnalytiXagility platform will be extended to execute instrumented annotation pipelines, yielding valuable data to improve those services. Scalability tests will be run.

Secondly, the service will be integrated with NHS systems to demonstrate how genomic data can form part of a patient’s electronic health record in a way that can be used in specialist care.

Clinically-led quality control will be built into the process and the outputs. Direct integration of clinical records from the NHS is also expected, along with qualitative measures of user acceptance demonstrated in an NHS setting.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,300+ scientific posters on ePosters
  • More than 4,800+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

University of Glasgow Researchers Make An Impact in 60 Seconds
Early-career researchers were invited to submit an engaging, dynamic and compelling 60 second video illuminating an aspect of their research.
Friday, November 20, 2015
Scientific News
Liquid Biopsies: Miracle Diagnostic or Next New Fad?
Thanks to the development of highly specific gene-amplification and sequencing technologies liquid biopsies access more biomarkers relevant to more cancers than ever before.
Colon Cancer Blocked in Mice
Case Western Reserve University Researchers block common type of colon cancer tumour in mice, laying groundwork for human clinical trial.
Discovered Through ‘Big Data’ Analysis
Researchers at the SBP have identified over 100 new genetic regions that affect the immune response to cancer.
New Therapeutic Targets For Small Cell Lung Cancer Identified
Researchers at UTSW Medical Center have identified a protein termed ASCL1 that is essential to the development of small cell lung cancer and that, when deleted in the lungs of mice, prevents the cancer from forming.
Deciphering Inactive X Chromosomes
Untangling the Barr body of inactive X chromosomes valuable for understanding chromosome structure and gene expression.
Micro Disease-Detecting Senor Created
Researchers at McMaster University have created a microscopic disease-detecting sensor that can turn on to detect trace amounts of substances.
Liquid Biopsies Treating Ovarian Cancer
Researchers have discovered a promising monitor and treat recurrence of ovarian cancer. Detecting cancer long before tumours reappear.
Uncovering a New Principle in Chemotherapy Resistance in Breast Cancer
The NIH study has revealed an entirely unexpected process for acquiring drug resistance that bypasses the need to re-establish DNA damage repair in breast cancers that have mutant BRCA1 or BRCA2 genes.
Understanding Treatment Resistant Melanoma
Researchers have determined how advanced melanoma becomes resistant; a development toward developing treatments.
Investigating ‘Black Box’ of Human Genetics
Investigations into inactive X chromosomes have shown unusual DNA repeat elements are essential for maintaining 3D structure.
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,300+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,800+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!